⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
globenewswire.com
CAPR
Medera to Participate in Oppenheimer Movers in Rare Disease Summit 2025
globenewswire.com
CAPR
Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
globenewswire.com
CAPR
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025
globenewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders to Inquire about Securities Investigation
accessnewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Connect
accessnewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Shareholders to Reach Out
accessnewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
CAPR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
CAPR
Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
CAPR